CAH vs IOSP · P/E 35, rev $254.25B vs P/E 18, rev $491.4M
Cardinal Health Inc (CAH) versus Innospec Inc (IOSP) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Innospec Inc (IOSP) is a specialty chemicals company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported IOSP revenue for 2026-06-30 was $491.4M. Net income was $30.8M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
Not investment advice. Open the CAH and IOSP stock pages for the full models.
Not investment advice.